Laronde
Biotechnology ResearchMassachusetts, United States11-50 Employees
Laronde is a biotechnology research company focused on expanding the boundaries of human biology through a programmable RNA platform. Its Endless RNA (eRNA) technology can be directed to produce diverse proteins within the body, with characteristics described as persistent, non-immunogenic, and capable of supporting repeat dosing, while offering flexibility in how it is formulated and delivered. The business was founded in 2017 by Flagship Labs, the innovation arm of Flagship Pioneering, and is headquartered in Cambridge, Massachusetts. The organization is scaling to advance multiple therapeutic programs across a range of disease areas. It operates within the biotechnology sector, positioning itself as a platform company that aims to enable new approaches to treating disease. By enabling programmable protein expression inside the body, the technology is intended to support development of therapies across diverse indications, potentially appealing to biopharmaceutical developers seeking novel modalities. In October 2023, Laronde announced a collaboration with Senda Biosciences, reflecting ongoing efforts to broaden its research and development footprint.
1-888-653-2347 
support@leadiq.com 
